Why Oxylogix exists.
Oxylogix was created to reduce biological risk in environments where failure carries serious consequences.
We work with organisations operating under regulatory oversight, contractual obligation, or audit scrutiny. In these environments, biosecurity decisions must be defensible, evidence led, and repeatable. Assumptions introduce risk. Vendor-led solutions create bias.
Our role is to bring control and confidence to biosecurity by separating independent investigation from solution delivery.
The problem was not technology. It was variability.
Across healthcare, food, travel and transportation, laboratories, and restoration, biosecurity outcomes often depend on manual effort, individual technique, and inconsistent processes.
That variability makes outcomes difficult to predict and even harder to defend during audits, incidents, or regulatory review.
The issue is rarely a lack of available technology. It is the absence of objective measurement, standardised decision making, and evidence led implementation.
That variability makes outcomes difficult to predict and even harder to defend during audits, incidents, or regulatory review.
The issue is rarely a lack of available technology. It is the absence of objective measurement, standardised decision making, and evidence led implementation.
Oxylogix exists to reduce that variability.
Independent assessment, backed by accredited
laboratory testing
Oxylogix connects organisations with independent, industry specific consultants who conduct on-site assessments and validated testing to quantify pathogenic load and other critical environmental risk factors.
These consultants work directly with you and remain independent of Oxylogix throughout the investigative and analytical phase.
Testing is conducted through accredited laboratories to ensure results are objective, verifiable, and defensible.
This separation ensures findings are not influenced by products, systems, or predefined solutions.
These consultants work directly with you and remain independent of Oxylogix throughout the investigative and analytical phase.
Testing is conducted through accredited laboratories to ensure results are objective, verifiable, and defensible.
This separation ensures findings are not influenced by products, systems, or predefined solutions.
Evidence before solutions
Once an independent laboratory report has been delivered, Oxylogix re-enters the project.
Our role is to interpret outcomes, assess operational implications, and define targeted, evidence based solution pathways aligned with regulatory expectations and operational reality.
Our role is to interpret outcomes, assess operational implications, and define targeted, evidence based solution pathways aligned with regulatory expectations and operational reality.
Solutions are recommended only after risk has been quantified and understood. This ensures decisions are driven by
evidence, not assumptions or sales incentives.
evidence, not assumptions or sales incentives.
Control through standardisation
Where solutions are implemented, Oxylogix focuses on reducing variability through controlled, repeatable treatment protocols.
Treatment cycles are defined. Exposure is consistent. Materials and sensitive infrastructure are protected.
The objective is not speed or automation. It is reliability, consistency, and confidence in outcomes across sites and teams.
Treatment cycles are defined. Exposure is consistent. Materials and sensitive infrastructure are protected.
The objective is not speed or automation. It is reliability, consistency, and confidence in outcomes across sites and teams.
Defined cycles
Treatment protocols are precise and repeatable
Consistent exposure
Every treatment delivers identical conditions
Material protection
Non-corrosive approach preserves assets
Outcomes, not equipment.
Systems and consumables are tools used to deliver outcomes. They are not the value on their own.
What matters is reduced biological risk, consistent results across locations, protection of sensitive assets, and clear alignment with regulatory expectations.
Our approach ensures outcomes are measurable, repeatable, and defensible when scrutiny matters.
Reduced biological risk
Consistent biosecurity across all treatments
Consistent results across locations
Standardised outcomes regardless of location
Protection of sensitive assets
Non-corrosive treatment preserves equipment
Clear alignment with regulatory expectations
Defensible documentation and verification
Designed to support regulated environments.
Oxylogix solutions are used in environments where compliance is non-negotiable.
We do not replace regulatory frameworks. We help organisations meet them more consistently by reducing reliance on manual variation and undocumented processes.
This enables clearer audit trails, stronger verification, and greater confidence during inspections or incidents.
We do not replace regulatory frameworks. We help organisations meet them more consistently by reducing reliance on manual variation and undocumented processes.
This enables clearer audit trails, stronger verification, and greater confidence during inspections or incidents.
Our role.
Oxylogix operates at the intersection of biosecurity, operational reality, and regulation.
We work with organisations that need practical, defensible approaches to managing biological risk. Not marketing promises or one-off treatments.
We work with organisations that need practical, defensible approaches to managing biological risk. Not marketing promises or one-off treatments.
Our value is independence, evidence, and disciplined execution.
Positioned at the intersection
- Biosecurity
- Operational reality
- Regulation
Technology partners.
Oxylogix works with established international manufacturers of dry vapour systems and consumables.
As an Australian distributor and operator, we provide local support, guidance, and continuity for clients. This structure allows the platform to expand over time as additional technologies and suppliers are introduced.
Technology selection follows evidence, not the other way around.
As an Australian distributor and operator, we provide local support, guidance, and continuity for clients. This structure allows the platform to expand over time as additional technologies and suppliers are introduced.
Technology selection follows evidence, not the other way around.
Based in Australia
Oxylogix supports organisations across Australia and New Zealand, working with both single-site operators and multi-location environments.
Oxylogix exists to bring control and confidence to biosecurity by separating independent investigation from solution delivery.
If you want to understand whether this approach fits your environment, we’re happy to have a conversation.